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controls matched on age and study entry date. We used 
national registers (95%) and hospital records (5%) to ascer-
tain cases. Diet was estimated by a modified diet history 
method. Plasma ENL concentrations were determined by a 
time-resolved fluoroimmunoassay. Odds ratios were calcu-
lated by unconditional logistic regression.
Results There were no significant associations between 
plasma ENL and incidence of all prostate cancer (odds ratio 
0.99 [95% confidence interval 0.77–1.280] for the highest 
ENL quintile versus lowest, p for trend 0.66). However, in 
certain subgroups of men, including men with abdominal 
obesity (p for interaction = 0.012), we observed associa-
tions between high ENL levels and lower odds of high-risk 
prostate cancer. Plasma ENL was positively associated with 
consumption of high-fibre bread, fruit, tea, and coffee; with 
age, and with height, while it was negatively associated with 
smoking and waist circumference; however, although signifi-
cant, all associations were rather weak (r ≤ |0.14|).
Conclusion ENL concentration was not consistently 
associated with lower prostate cancer risk, although it was 
weakly associated with a healthy lifestyle.
Keywords Diet · Prostate cancer · Nested case–control · 
Lignans · Enterolactone
Introduction
Estrogen is important to the development and differentia-
tion of the prostate, although our knowledge of the details 
is incomplete [1]. Lignans constitutes, besides isoflavones 
(e.g., genistein and daidzein, which are mainly found in 
soy products) and coumestans (mainly found in sprouts), 
one of the three main classes of phytoestrogens (PE), non-
steroidal plant-based substances with estrogenic properties. 
Abstract 
Purpose Enterolactone (ENL) is formed in the human 
gut after consumption of lignans, has estrogenic properties, 
and has been associated with risk of prostate cancer. We 
examined the association between plasma ENL levels and 
prostate cancer in a nested case–control study within the 
population-based Malmö Diet and Cancer cohort. We also 
examined the association between plasma ENL and dietary 
and lifestyle factors.
Methods The study population consisted of 1010 cases 
occurring during a mean follow-up of 14.6 years, and 1817 
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In European populations, the lignans is the most important 
PE class [2]. Lignans are found in plant foods, including 
flax seeds, fruits, berries, vegetables, and whole-grain foods, 
which are also important sources of dietary fibre. However, 
other lignan sources exist, including coffee, tea, fruit juice, 
and wine [3, 4]. Enterolactone (ENL) is an enterolignan, 
which in humans is formed in the gut from various dietary 
lignans through the action of colonic bacteria, and is later 
detectable in the circulation [5]. ENL has been shown to 
activate estrogen receptors α and β of the prostate in vivo 
[6], and may also, for example, modulate the bioavailabil-
ity of steroidal hormones through competitive binding to 
sex hormone binding globulin (SHBG) [7]. Several stud-
ies have shown protective associations between intake of 
PE-rich foods, calculated intake of PE and levels of PE in 
blood or urine, and risk of prostate cancer [8], but most of 
these findings have been due to isoflavones, which are not 
generally consumed in large amounts in Europe and North 
America [8, 9]. International prospective studies have found 
no association between serum ENL and prostate cancer [10, 
11], but a recent meta-analysis by He and Wang et al. [12], 
including 2 population-based case–control and 4 nested 
case–control studies, did provide support for a protective 
association (OR for highest vs. lowest ENL category 0.76, 
95% confidence interval 0.60–0.97), although the support 
from the population-based case–control studies was stronger 
than that from the nested case–control studies.
In epidemiological studies, ENL concentrations have 
repeatedly been positively associated with consumption of 
vegetables, fibre, coffee/caffeine, fruits and berries, whole-
grain/high-fibre bread, alcohol/wine and higher education, 
and negatively associated with recent antibiotic use, smok-
ing, weight/body mass index (BMI), and frequency of def-
ecation [5]; it might thus also be regarded as a potential 
biomarker of a healthy lifestyle. Furthermore, both body 
composition (e.g., obesity in general [13] and fat distribution 
[14]), height [15] and smoking [16] have been implicated as 
risk factors of prostate cancer.
Thus, the aim of this study was to examine the associa-
tion between plasma ENL levels and risk of prostate cancer 
in a population-based cohort. We also aimed to examine 
associations between diet, lifestyle, and body composition 
and ENL levels in middle-aged men, since most previous 
studies on ENL levels have been focused on women, with a 
few exceptions [17–19].
Methods
The Malmö diet and cancer cohort
The Malmö Diet and Cancer (MDC) cohort is a population-
based prospective cohort set in the South of Sweden. In 
1991, the source population was defined as all persons liv-
ing in the city of Malmö and born between 1926 and 1945, 
with Swedish reading and writing skills. In May 1995, the 
cohort was extended to include all women born between 
1923 and 1950 and all men born between 1923 and 1945. 
With this extension, 74,138 persons constituted the source 
population. Details of the recruitment procedures and the 
cohort are described elsewhere [20–23]. With a participation 
rate of approximately 40%, the cohort consists of 28,098 
participants, of whom 11,063 are men.
Data collection
The study subjects visited the MDC study centre twice 
(median time between visits: 16 days). At the first visit, die-
tary interviewers provided information on the background 
and aim of the project, and detailed instructions about the 
dietary assessment and the other procedures of the study, 
including the lifestyle questionnaire. Non-fasting blood sam-
ples were drawn from all participants (see below). Anthrom-
pometric measurements and blood pressure were measured 
by the study nurses. During the second visit, a dietary inter-
view was performed (see below), and the lifestyle question-
naires were checked for incomplete answers.
Clinical data and case ascertainment
In this study, we excluded men with cancer (except for non-
melanoma skin cancers) at baseline (n = 485), resulting in 
a background population of 10,578 men. Incident prostate 
cancer cases were identified by linkage of personal identi-
fication numbers with the Swedish Cancer Register (SCR); 
the SCR is known to be at least 96% complete [24]. During 
follow-up until 31st December 2009 (mean 14.6 years), a 
total of 1016 first-time prostate cancer cases were identified 
by linkage of the MDC cohort to the SCR.
The controls were sampled from a previous case–control 
selection from the MDC cohort, consisting of all prostate 
cancer cases (including prostate cancer both as first-time and 
subsequent cancer) and three controls per case, matched on 
age and date of entry into the study [25]. Because of logistic 
and funding restrictions, we randomly sampled two of the 
three controls from this selection for each eligible case if 
controls were free of all cancers (except non-melanoma skin 
cancers). Due to the more relaxed inclusion criteria of cases 
and controls in the previous selection, we only included 
1828 matched controls in our study.
Data on the clinical and histological characteristics of the 
tumours were collected from the National Prostate Cancer 
Register (NPCR), which covers cases from 1996 and onward. 
Data on cases that occurred between 1991 and 1995 (n = 54) 
were manually extracted from medical records using stand-
ard routines. A validation of the NPCR data showed high 
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validity for all variables, including the variables used in the 
classification of tumours by case severity in this study [26].
High-risk prostate cancer cases (n = 356) were defined 
as local clinical tumour stage T3 or T4, presence of lymph 
node metastasis (N1), bone metastasis (M1), Gleason score 
8 or higher, or serum PSA levels above 50 ng/mL [27]. 
Tumours were also classified as high-risk if WHO grade 
was three, and Gleason score was unavailable (n = 6). All 
other tumours were classified as low-risk cases (n = 651). 
Clinical data were insufficient for classification of nine cases 
as low- or high risk.
Health-conscious men may be prone to attend regular 
health checks including PSA testing and thus more likely 
to be diagnosed with prostate cancer at an early stage. This 
health-conscious behaviour may cause a potential bias when 
investigating associations between diet and prostate cancer. 
We, therefore, also investigated symptomatic cases (defined 
as men who presented with lower urinary tract symptoms or 
other malignancy-related symptoms) separately (n = 469).
Anthropometric measurements
Anthropometric measurements were taken by trained project 
staff and obtained from subjects without shoes and wearing 
light indoor clothing. Body mass index (BMI) was defined 
as weight (kg) divided by height (m) squared. Waist circum-
ference (cm) was measured midway between the lowest rib 
margin and iliac crest. Abdominal obesity was defined as a 
waist circumference of at least 94 cm [28].
Blood sample handling and analysis
The samples were processed and separated for plasma within 
1 h of drawing, as described previously [29]. The samples 
were stored at −80°C until analysis. The quality control pro-
gram of the biobank in the MDC study has been described 
previously [30].
Plasma ENL concentrations were determined by time-
resolved fluoroimmunoassay as reported previously [31, 
32]. In brief, samples were incubated overnight with a 
mixture of sulphatase and β-glucuronidase, and uncon-
jugated ENL was extracted with diethyl ether. Sample 
extracts were then diluted in assay buffer, added with 
antiserum and europium-labelled and placed in pre-
washed goat anti-rabbit IgG microstrips to be analysed 
by Auto-DELFIA 1235 Automatic Immunoassay System. 
3H-estradiol glucuronide was used as internal standard. All 
analyses with the automatic instrument were carried out in 
duplicate. The lower detection limit was 1.5 nmol/L [32]; 
227 controls and 130 cases had lower values and were 
therefore counted as having zero ENL. During the assay 
development, the intraassay coefficient of variation (CV) 
varied from 3.3 to 6.0% in the concentrations from 13.2 to 
79.5 nmol/L. The interassay CV varied from 6.9 to 9.9% in 
concentrations from 16.3 to 96.6 nmol/L [32]. The intra-
class correlation (ICC) for repeated samples in non-fasting 
individuals over 5 weeks has been reported to be 0.48 in 
Malmö [33]. Seventeen measurements failed because of 
technical reasons, leaving 2827 individuals (1010 cases 
and 1817 controls) for analysis. The analysing staff was 
blinded to the case–control status of the samples.
Dietary assessment
Dietary information was collected using a modified diet his-
tory method, combining a 168-item quantitative diet history 
questionnaire (using exact frequencies and picture booklet to 
assess portion sizes), a 7-day registration (collecting descrip-
tions of prepared meals, nutrient supplements and cold bev-
erages), and a 45–60 min dietary interview. Energy and 
nutrient intakes were computed from the total reported food 
intake using the MDC Food and Nutrient Database, mainly 
originating from PC Kost2-93 of the Swedish National Food 
Administration. Data on the validity [34, 35] and reproduc-
ibility [36] of the method have been published.
The food and nutrient variables investigated in this study 
were high-fibre bread, vegetables, fruits and berries, fruit 
juices, coffee, tea, wine, macronutrients, and dietary fibre. 
These dietary variables were selected for being sources of 
dietary lignans and from previous literature on associa-
tions between foods and blood ENL levels [17, 19, 37, 38]. 
Energy percentages of macronutrients were calculated with 
estimated non-alcohol energy intake, as were fibre intakes 
per 1000 kcals. The food variables were energy-adjusted 
by the residual method (ln-transformed data) [39]. A small 
constant (corresponding to the lowest value of the distri-
bution) was added to all values before ln-transformation. 
Due to the large number of zero consumers in several food 
groups, and to skewed intake data, the food group variable 
distributions were divided into quantiles when used in asso-
ciation tests. Depending on the number of zero consumers 
(less than 10% or between 10 and 20% of the population), 
the distributions were divided into either deciles (vegeta-
bles, fruit and berries, and coffee) or quintiles (high-fibre 
bread), respectively. If the proportion of zero consumers was 
greater than 20%, the zero consumers alone were put into the 
lowest group, while the rest of the population was divided 
into quartiles (fruit juice, tea, and wine). Similarly, the ENL 
distribution was positively skewed and contained a relatively 
large number of zero measurements; it was therefore divided 
into quintiles.
For men of the MDC cohort, the relative energy-adjusted 
validity coefficients (compared to 18 days of weighed foods 
records) were for dietary fibre 0.74, vegetables 0.65, fruits 
0.60, bread 0.50, and wine 0.53 [34].
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Other variables
Information on age was obtained through the Swedish per-
sonal identification number, which includes date of birth. 
A structured questionnaire covering socio-economic and 
lifestyle factors was completed by the participants. The 
agreement between the baseline questionnaire and the same 
questionnaire when repeated after 3 weeks was high for 
most variables (kappa values >0.75) [22]. Educational level 
was defined according to the number of years of education 
completed or degree of educational level attained: elemen-
tary, primary and secondary, upper secondary, or univer-
sity degree (including further education without degree). 
Smoking was defined as never, former, or current smokers 
(including irregular smokers). Alcohol habits were classi-
fied as none during last month, low (<20 g/day), moderate 
(20–40 g/day), or high (>40 g/day). Physical activity level 
was calculated from estimates of average daily total physi-
cal activity for each participant [40]. Prevalence of diabetes 
mellitus (yes/no) was based on information from national 
and local registries. Current use of antibiotics was assessed 
from self-reported information in the 7-day menu book. 
Participants were previously classified as potential under-, 
adequate or over reporters of energy intake [40] using the 
approach described by Goldberg et al. [41] and later refined 
by Black [42]. Individuals with potentially unstable dietary 
habits were identified by the questionnaire item ‘Have you 
substantially changed your food habits in the past due to ill-
ness or other reason?’ [43].
Statistical methods
The ENL levels, and background characteristics and dietary 
factors for PCa cases and controls were tabulated; these dif-
ferences were examined by Kendall’s tau-b, Mann–Whit-
ney and Student’s t tests, the latter on ln-transformed data. 
Most tests involving continuous variables were similarly 
performed on ln-transformed data to correct for skewed 
distributions.
We examined the associations between quintiles of 
plasma ENL among the controls and risk of total, low-
risk, high-risk, and symptomatic prostate cancer by 
unconditional logistic regression, with adjustment for 
matching variables (age and baseline date), season, edu-
cational level, smoking status, height, and waist circum-
ference; the latter variable selected in preference to BMI 
based on association with plasma ENL (see below) and 
on previous research [14]. These main associations were 
further adjusted for consumption of fermented and non-
fermented milk and dietary intake of calcium, selenium or 
zinc. These variables were all selected based on previous 
scientific literature. Since obesity [13] and smoking [16] 
have been reported to be associated with PCa mortality, 
and height with PCa incidence [15], we also examined if 
the results differed by groups defined by waist circumfer-
ence (<94/≥94 cm) [28], height (split by median), and 
smoking status. Due to missing values, 1008 cases and 
1817 controls were included in the multivariable analyses.
We tabulated the distributions of anthropometric, other 
background variables and dietary factors among controls 
by quintiles of plasma ENL. Associations between the 
ENL quintiles (categorical) and the continuous other vari-
ables were tested with Spearman’s correlation tests. We 
also listed the distributions of the various background fac-
tors by quintiles of plasma ENL among the controls. These 
associations were tested with Kendall’s tau-b for ordinal 
variables and χ2 tests for nominal variables.
In the next step, the multivariable associations between 
the selected dietary and body composition variables and 
plasma ENL deciles among the controls (n = 1807) were 
determined. We first calculated partial correlation coeffi-
cients between the individual predictor variables (adjusted 
for age, baseline date, season, and total energy intake 
where applicable) and plasma ENL. We also constructed 
a model in which all food variables were entered simulta-
neously with the same adjustment as the first model (mul-
tivariable food model). Finally, we designed a regression 
model in which all dietary variables and potential con-
founders (BMI, waist, height, smoking status, educational 
status, and physical activity level) were eligible for step-
wise (backwards) elimination (elimination criterion was 
p > = 0.10), with adjustment for age, baseline date, and 
total energy (Full multivariable model). The median values 
of the food quantiles were used to represent the quantiles 
in these analyses.
The analyses were repeated with exclusion of individu-
als who reported dietary change in the past (to include only 
individuals more likely to have stable food habits and conse-
quently more stable long-term lignan intake and subsequent 
ENL concentrations). We also repeated the main analyses 
after exclusion of men with ENL values below the detec-
tion limit, and after exclusion of PCa cases occurring within 
2 years of blood sampling.
We used the SPSS statistical software version 20 (IBM 
Corp, U.S.A.) for all analyses, except the calculations of 
geometric means with confidence intervals, and a post-hoc 
restricted cubic spline (piecewise) regression on the asso-
ciation between plasma ENL (spline with 3 knots, selected 
based on Harrell’s recommended percentiles) and risk of 
high-risk prostate cancer, for which we used Stata version 
12.1 (StataCorp LP, U.S.A). The spline was fitted to examine 
the assumption of a linear association and to identify poten-
tial threshold levels in case of non-linearity. The likelihood-
ratio test was used to test for linearity of the association by 
comparing the fit of the linear model to a model that addi-
tionally included the cubic spline.
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Results
Association between ENL and prostate cancer risk
Mean arithmetic plasma ENL among controls and cases 
were 16.5 (SD 21.0) and 16.3 (SD 16.7) nmol/L, respec-
tively; the corresponding median values were 11.9 and 
11.7. There were few differences between cases and con-
trols in terms of unadjusted ENL levels, dietary intakes, 
and background factors (Tables 1, 2). The most signifi-
cant difference between cases and controls was the slightly 
higher proportion of current smokers and low-educated 
men among controls (Table 1) and the somewhat higher 
consumption of high-fibre bread among cases (Table 2).
We observed no significant associations between 
plasma ENL and incidence of total, low-risk, high-risk, 
or symptomatic prostate cancer, although we did note a 
significantly lower odds ratio for high-risk prostate cancer 
(0.60; 95% CI 0.40–0.89) in the fourth compared with the 
first quintile of the ENL distribution (Table 3). Adjustment 
for consumption of fermented and non-fermented milk or 
dietary intake of calcium, selenium, or zinc did not change 
the results (data not shown).
Table 1  Background 
characteristics of cases of 
prostate cancer and controls 
in a nested case–control study 
within the Malmö diet and 
cancer cohort, 1991–2009
Continuous variables: mean (SD) and t tests
Categorical variables: numbers (%), Kendall’s tau-b, except where noted
BMI body mass index, WHR waist–hip ratio
a Ratio of total calculated energy expenditure to calculated basal metabolic rate [35]
b Fisher’s exact test
Variable Cases (n = 1010) Controls (n = 1817) p value
Mean (SD)
 Age (years) 60.8 (6.6) 60.6 (6.6) 0.33
 Height (cm) 176.6 (6.6) 176.2 (6.4) 0.084
 Weight (cm) 81.8 (11.6) 81.5 (11.8) 0.64
 BMI (kg/m2) 26.2 (3.4) 26.2 (3.4) 0.67
 Waist (cm) 93.8 (9.8) 93.7 (9.9) 0.88
 WHR 0.94 (0.06) 0.94 (0.06) 0.54
 Body fat  % 20.6 (4.8) 20.8 (4.9) 0.36
 Physical activity  levela 1.58 (0.35) 1.60 (0.37) 0.24
N (%)
 Educational status 0.043
  Elementary 445 (44) 848 (47)
  Primary and secondary 182 (18) 368 (20)
  Upper secondary 126 (13) 191 (11)
  Further education/University degree 255 (25) 404 (22)
 Smoking status 0.017
  Never-smokers 316 (31) 524 (29)
  Former smokers 468 (46) 800 (44)
  Current smoker 226 (22) 490 (27)
 Alcohol habits 0.50
  Zero consumers 67 (7) 134 (7)
  <20 g alcohol per day 666 (66) 1201 (66)
  20–40 g alcohol per day 212 (21) 362 (20)
  >40 g alcohol per day 65 (6) 120 (7)
 Physical activity level 0.66
  Quartile 1 251 (25) 455 (25)
  Quartile 2 254 (25) 453 (25)
  Quartile 3 266 (26) 441 (24)
  Quartile 4 239 (24) 468 (26)
 Prevalent diabetes 0.43b
  Yes 38 (4) 80 (4)
  No 972 (96) 1737 (96)
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Table 2  Mean plasma 
enterolactone and dietary 
intakes of macronutrients 
and food sources of lignans 
in prostate cancer cases and 
controls of the Malmö Diet and 
Cancer cohort 1991–2009
Geometric means (95% confidence intervals), except where noted
E% energy percentage
a Mann–Whitney tests, except where noted
b Arithmetic means (SD)
c Student’s t tests
Variable Cases (n = 1010) Controls (n = 1817) p  valuea
Plasma enterolactone (nmol/L) 13.4 (12.7–14.2) 13.5 (12.9–14.0) 0.91
Dietary energy (kcals)b 2590 (670) 2620 (650) 0.21c
Fat (E%)b 39.8 (6.3) 39.7 (6.3) 0.65c
Carbohydrates (E%)b 44.6 (6.0) 44.8 (6.1) 0.45c
Protein (E%)b 15.6 (2.4) 15.5 (2.5) 0.49c
Fibre (g per 1000 kcals)b 8.95 (2.5) 8.86 (2.7) 0.37c
High-fibre bread (g) 24.3 (22.5–26.2) 23.8 (22.4–25.2) 0.041
Vegetables (g) 147 (142–153) 145 (140–149) 0.34
Fruit and berries (g) 140 (133–147) 135 (130–140) 0.26
Fruit juice (g) 22.5 (18.1–28.0) 26.8 (22.7–31.6) 0.25
Coffee (g) 406 (386–427) 406 (391–421) 0.96
Tea (g) 194 (178–212) 187 (175–199) 0.067
Wine (g) 65.8 (61.0–71.0) 69.1 (65.4–73.0) 0.11
Table 3  Odds ratios (with 95% confidence intervals within parentheses) for prostate cancer by quintiles of plasma enterolactone concentration 
in a nested case–control study of men within the MDC cohort, 1991–2009
Plasma enterolactone was treated as a categorical variable, with median quantile values representing the quantiles in these analyses
Q quintile
a Unconditional logistic regression model adjusted for age, baseline date, and season
b Model additionally adjusted for height (continuous), waist circumference (continuous), educational level (categorical), and smoking status (cat-
egorical)
c Other cases counted as missing
Median plasma enterol-
actone (nmol/L)
Q1 Q2 Q3 Q4 Q5 P for trend
0 6.2 11.9 19.7 36.0
All prostate cancer (n = 1010)
 No. events 201 211 204 181 213
 Model  1a 1.00 (ref) 1.01 (0.80–1.30) 0.99 (0.78–1.27) 0.84 (0.66–1.08) 1.06 (0.83–1.36) 0.89
 Model  2b 1.00 (ref) 1.01 (0.79–1.29) 0.97 (0.76–1.24) 0.80 (0.63–1.04) 0.99 (0.77–1.28) 0.66
Low-risk prostate cancer (n = 648)c
 No. events 128 131 130 131 128
 Model  1a 1.00 (ref) 1.00 (0.75–1.34) 1.01 (0.76–1.35) 0.98 (0.74–1.31) 1.05 (0.79–1.42) 0.73
 Model  2b 1.00 (ref) 0.98 (0.74–1.31) 0.97 (0.73–1.30) 0.93 (0.69–1.24) 0.97 (0.72–1.31) 0.77
High-risk prostate cancer (n = 353)c
 No. events 71 77 73 48 84
 Model  1a 1.00 (ref) 1.01 (0.71–1.45) 0.96 (0.67–1.38) 0.60 (0.41–0.90) 1.05 (0.73–1.52) 0.82
 Model  2b 1.00 (ref) 1.01 (0.71–1.46) 0.95 (0.66–1.38) 0.60 (0.40–0.89) 1.02 (0.70–1.47) 0.67
Symptomatic prostate cancer (n = 465)c
 No. events 87 88 111 83 96
 Model  1a 1.00 (ref) 0.97 (0.69–1.35) 1.23 (0.89–1.69) 0.89 (0.63–1.24) 1.08 (0.77–1.51) 0.86
 Model  2b 1.00 (ref) 0.95 (0.68–1.33) 1.19 (0.86–1.65) 0.84 (0.59–1.18) 0.99 (0.70–1.40) 0.72
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Because of the lower odds ratio of high-risk prostate 
cancer in the fourth quintile of the ENL distribution, we 
wanted to examine whether there was a non-linear associa-
tion between ENL and OR of high-risk prostate cancer. We 
thus performed a restricted cubic spline regression (see “Sta-
tistical methods”). A model adding the cubic spline to the 
original linear model did not differ significantly from the 
original model (likelihood-ratio test, p = 0.27). However, 
a model containing only the spline variable and the covari-
ates revealed that the slopes of the second and third parts of 
the ENL spline curve were significantly different from the 
first (p = 0.028 and 0.022, respectively), indicating a certain 
degree of non-linearity (Supplemental Figure 1).
The prostate cancer-ENL associations did not differ by 
height (<=176/>176 cm, Supplementary Table 1). We noted 
a significantly inverse association between plasma ENL and 
risk of high-risk prostate cancer among men with a waist cir-
cumference of >94 cm (Q5 vs Q1: OR = 0.65 (0.37–1.12), p 
for trend = 0.024), but not among men with smaller waists (p 
for interaction = 0.012; Supplementary Table 1). No signifi-
cant trends were noted for the other prostate cancer catego-
ries after stratifying by waist circumference. After stratifi-
cation on smoking status, we observed no significant trends 
between plasma ENL and risk of any category of prostate 
cancer, except in current smokers, among whom we noted 
an inverse association between ENL concentration and risk 
of symptomatic cancer (p = 0.028; Supplementary Table 1). 
However, this interaction was not statistically significant (p 
for interaction = 0.13).
Sensitivity analyses
When we excluded men who had reported a substantial 
change in dietary habits, the ENL associations with prostate 
cancer were generally weaker. The OR for high-risk cancer 
in the fourth ENL quintile of high-risk cancer was, however, 
slightly lower than before [Supplementary Table 2; model 2: 
OR 0.53 (0.34–0.85), p = 0.008]. Furthermore, the associa-
tions with prostate cancer were even weaker after removal of 
individuals with ENL levels below the detection limit. After 
exclusion of cases occurring within 2 years of sampling, the 
results were basically unchanged, although a few of the trend 
tests had their p values increased; none of which changed 
any previously significant results.
Determinants of ENL concentrations
The highest ENL concentrations were seen in older, taller, 
and more highly educated men (Supplementary Tables 3, 
4). The lowest concentrations were seen among men with 
central adiposity (large waist circumference), general obe-
sity (BMI), and in current smokers. Furthermore, persons 
who reported having changed their diet had higher levels 
than non-changers, and persons who were estimated to 
have reported their energy intake adequately had higher 
levels than under reporters of energy. ENL levels differed 
by season of sampling, with the lowest levels seen during 
summer (Table 4). We noted, however, that the associa-
tion with age was mainly due to the considerably higher 
ENL levels among the oldest age group (70+): mean 31.0 
(standard error of the mean [SEM] 3.2) nmol/L among 
those at least 70 years (n = 200), compared to 14.7 (SEM 
0.4) nmol/L among the younger men (t test for difference 
p < 0.001; data not tabulated).
After adjustment for potential confounders, energy 
percentage from fat was significantly and negatively 
associated with plasma ENL levels (r = −0.10), while 
fibre (r = 0.19) and carbohydrate (r = 0.11) intake were 
positively associated with ENL (Table 4). Consumption 
of high-fibre bread, fruit, tea, and vegetables was posi-
tively associated with plasma ENL (r = 0.06–0.12). Fur-
thermore, BMI, waist circumference, and smoking status 
were negatively associated with ENL, while height was 
positively associated.
When the food variables were entered simultane-
ously (multivariable food model), the associations were 
slightly weaker, but all previously statistically significant 
food variables (except vegetables) were still significantly 
associated with ENL. Furthermore, coffee consumption 
showed a weakly positive correlation (r = 0.047) with 
ENL (Table 4).
In the full multivariable model, the same food variables 
(and height) were still significantly positively correlated 
(although mostly weaker, with r values ranging from 0.06 
to 0.08) with ENL, while waist circumference, smoking 
status, and total energy intake were negatively correlated 
with ENL (Table 4). This model explained 9.9% of the 
total ENL variation (adjusted R2).
Post‑hoc analyses
After noting that plasma ENL levels were clearly higher 
among men of at least 70 years of age, we examined the 
associations between ENL and PCa risk in men older 
and younger than 70 years (Supplementary Table 5). We 
observed a general tendency to decreased risk at higher 
ENL values in men who were at least 70 years. For total 
prostate cancer, the odds ratio of the highest ENL quintile 
compared to the lowest was 0.53 (95% CI 0.20–1.37, p 
for trend = 0.059, p for interaction = 0.062). For low-
risk and high-risk prostate cancers, the associations were 
somewhat weaker. For symptomatic cancer, however, the 
OR for the highest quintile was 0.40 (95% C.I. 0.12–1.24, 
p for trend = 0.027, p for interaction = 0.023).
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Discussion
There were no significant associations between plasma ENL 
and incidence of total, low- or high-risk or symptomatic 
prostate cancer. The results were similar in men above and 
below median height. However, we noted that higher ENL 
levels were associated with lower risk of high-risk cancer 
in men with abdominal obesity and with symptomatic can-
cer among smoking men. We also noted a similar associa-
tion between ENL and risk of symptomatic prostate cancer 
among men at least 70 years. We found ENL in plasma to be 
associated with consumption of high-fibre bread, fruit and 
berries, tea, and coffee after adjustment for several potential 
confounders. It was also positively associated with being at 
least 70 years of age, and having a greater height. It was neg-
atively associated with smoking and waist circumference.
In general, plasma ENL was not associated with prostate 
cancer risk in this study. A few, mostly nested case–control 
studies have reported lower ENL concentrations in prostate 
cancer cases than in controls [12, 44], with one study also 
reporting an interaction between an ENL and an SNP in 
the MSMB gene [45]. In contrast, most prospective studies 
have found no association [10, 11, 46–48]. A recent meta-
analysis found a protective association [12], but, again, the 
latter result was partly driven by data from retrospective 
case–control studies. An updated meta-analysis [49] noted 
protective associations between some PE (notably the iso-
flavones daidzein, genistein, and glyciteine) and PCa, while 
there was little evidence of effects of dietary lignans and 
enterolignans such as ENL, although the authors note that 
their analysis on ENL was hampered by heterogeneity of 
the included studies [49]. We observed lower risk of symp-
tomatic prostate cancer at higher levels of plasma ENL in 
older men and in current smokers, and lower risk of high-
risk cancer in men with abdominal obesity, although these 
findings could be spurious. It is noteworthy, however, that 
these findings concerned high-risk and symptomatic cancers, 
and were noted among smoking, older, and obese men and 
groups that have been implicated in aggressive and/or fatal 
prostate cancer [50, 51].
Table 4  Partial correlations 
between quintiles of plasma 
enterolactone (dependent) and 
anthropometric and energy-
adjusted dietary variables 
(independent) among 1817 male 
controls of a nested case-control 
study within the Malmö Diet 
and Cancer cohort (1991-2009)
r partial correlation coefficient; E% energy percentage; BMI body mass index
Food variables expressed as medians of quantiles (deciles, except where noted)
a Adjusted for age, baseline date, season, and total energy  (loge-transformed)
b As the separate models, but with food variables (quantiles) included simultaneously
c Stepwise backward linear regression model with all food variables (quantiles), BMI (loge-transformed; 
NS), waist (loge-transformed), height  (loge-transformed), smoking status, educational status (NS), physical 
activity level (NS), adjusted for age, baseline date, season and total energy  (loge-transformed); N.S. is an 
eliminated variable with P > 0.10
d Non-alcohol energy percentage
e Adjusted for age, baseline date, and season
f Never-smokers (category 1), ex-smokers (category 2) and current smokers (category 3)
Variable Separate  modelsa Multivariable food 
 modelb
Full multivariable 
 modelc
r P r P r P
Energy (kcal) -0.043 0.067 -0.045 0.067 -0.059 0.012
Fat (E%)d -0.102 <0.001
Protein (E%)d -0.023 0.32
Carbohydrates (E%)d 0.111 <0.001
Dietary fibre per 1000 kcal 0.190 <0.001
High-fibre bread (g) 0.124 <0.001 0.095 <0.001 0.083 <0.001
Vegetables  (g) 0.064 0.007 0.019 0.42 NS
Fruit and berries (g) 0.100 <0.001 0.072 0.002 0.071 0.003
Fruit juice (g; 4 cat + zero) 0.028 0.23 0.017 0.46 NS
Coffee (g) 0.022 0.35 0.047 0.047 0.059 0.012
Tea (g; 4 cat + zero) 0.069 0.003 0.061 0.009 0.055 0.019
Wine (g; 4 cat + zero) 0.033 0.15 0.009 0.70 NS
Height (cm) 0.085e <0.001 0.107 <0.001
BMI (kg/m2) -0.104e <0.001 NS
Waist (cm) -0.110e <0.001 -0.136 <0.001
Smoking  statusf -0.120 <0.001 -0.089 <0.001
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Our findings on positive associations between plasma 
ENL and lignan-containing foods and dietary fibre, and neg-
ative associations between ENL and smoking and obesity, 
were generally in agreement with several previous studies 
[17, 18, 38, 52, 53], including one on women from the same 
cohort [54]. In general, the correlation coefficients in our 
study were rather low, but comparable with the previous 
literature. A recent validation study, evaluating two food fre-
quency questionnaires designed for the estimation of lignan 
intake, showed a correlation between total lignan intake and 
serum ENL of 0.22 for one of the FFQ:s and 0.09 for the 
other [37]. Thus, predicting ENL levels from dietary data 
is a difficult task. Our study also gives some support to the 
idea that ENL concentration may be regarded as a marker 
of a healthy lifestyle, due to the negative associations with 
smoking and obesity, and positive associations with many 
foods that contain fibre and lignans [5].
We observed notably higher ENL levels in men older 
than 70 years. This is a less common finding in the litera-
ture. One exception is a Finnish study, in which age was 
positively associated with ENL levels in women, but not in 
men. The cause of this finding is unclear. One possibility is 
confounding by constipation, on which we had no informa-
tion in this study. Several authors have found constipation 
be important to the concentration of ENL in plasma [17, 18, 
38]. For example: in the study by Kilkkinen et al. [17], con-
stipation was more strongly associated with ENL levels than 
consumption of either whole grains, vegetables or fruit and 
berries among men. Similarly, in the Dutch endoscopy popu-
lation studied by Milder et al., a lower frequency of defeca-
tion was as strongly associated with ENL as a hypothesized 
increase in lignan intake of 3–8 standard deviations [18]. 
According to a study by Wald et al., the prevalence of consti-
pation among men older than 60 years in the Western world 
is around 10%, while it is only around 6% in 45–59-year-old 
men [55]. Thus, a lower defecation frequency among older 
men might partly explain their higher ENL levels.
Major strengths of our study include the dietary assess-
ment—which is based on a modified diet history method that 
includes elements of diet recording [56], and produces data 
of high relative validity—direct body composition meas-
urements and extensive background information, including 
information on dietary change. Furthermore, this is one of 
the largest prospective studies on ENL and risk of prostate 
cancer to date. The loss to follow-up is minimal, and the 
clinical data are of good quality.
Our study also had some potential weaknesses. The 
intake of lignans in this population is rather low, at least 
compared to the other European cohorts participating in 
the EPIC project [9]. This leads to a comparably narrow 
intake distribution, which lowers the chance of observ-
ing a potential effect. Some Swedish studies have previ-
ously reported similarly low ENL concentrations, but at 
least one Swedish study reported higher concentrations of 
above 20 nmol/L [19]. In that study, the geometric means 
for cases were 15.3 nmol/L and those for controls were 
21.4 nmol/L, as compared to 13.4 nmol/L for cases and 
13.5 nmol/L for controls in our study (Table 2). The cited 
study was carried out in a different patient population in 
a different part of Sweden (Stockholm area). Importantly, 
both studies used the same quantitative, strictly validated 
method [31, 32]. Thus, the slight differences in ENL con-
centrations (and the different proportions of participants 
below the detection limit) most likely reflect different 
intakes between the populations.
We only had information on antibiotic use during the 
diet registration period of 7 days; furthermore, most par-
ticipants had their blood drawn several days before the 
registration. It has been shown that ENL levels may be 
significantly lower in antibiotic users up to 16 months after 
use, presumably through an effect on colonic microbiota 
[57]. This might obscure any associations between ENL 
levels and foods or risk of prostate cancer.
We also had only one measurement of plasma ENL. 
Although the intra-class correlation coefficient (ICC) 
has been reported to be fair (0.44) for a period of up to 
3 years [58], the blood in our study was drawn from non-
fasting persons. We have previously estimated the ICC 
for repeated non-fasting samples during a 5-week period 
to be 0.48 (95% CI, 0.22–0.72) in women of the MDC 
cohort [33], which certainly could deflate the measured 
associations.
We lack information on prostate cancer among close 
relatives of the participants. Since family history is one 
of the few established risk factors of prostate cancer, this 
lowers the precision of our estimates. However, family his-
tory is unlikely to be a major influence on ENL levels, and 
is thus probably not a confounder in this context.
As always, the risk of residual confounding and of 
chance findings, particularly in studies performing large 
numbers of statistical tests, must always be considered.
To conclude, this population-based prospective study 
showed no consistent associations between high levels of 
plasma ENL and subsequent risk of prostate cancer, which 
is in line with other prospective studies. We did, however, 
observe lower risks of high risk or symptomatic cancer at 
higher ENL levels in men with central adiposity, current 
smokers, and men who were at least 70 years, respectively. 
The latter findings are suggestive, but would need to be 
confirmed in other studies. The study also showed that 
plasma ENL is a weak marker of consumption of foods 
such as fruit and berries, tea, and coffee in middle-aged 
Swedish men. It might possibly be regarded as a marker of 
a healthy lifestyle, since it was also associated with lower 
likelihood of smoking and obesity.
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